The next advance in treating major depression may relate to a group of brain chemicals that are involved in virtually all our brain activity, according to a new study. This study shows that compared to healthy individuals, people who have major depressive disorder have altered functions of the neurotransmitter GABA (gamma-aminobutyric acid).